Bill
Bill > SB656
MD SB656
MD SB656Public Health - Cosmetic Products - Enforcement and Penalties for Prohibited Ingredients (Crown and Care Act - Protecting Communities from Harmful Hair Chemicals)
summary
Introduced
02/06/2026
02/06/2026
In Committee
04/03/2026
04/03/2026
Crossed Over
03/19/2026
03/19/2026
Passed
04/28/2026
04/28/2026
Dead
Signed/Enacted/Adopted
04/28/2026
04/28/2026
Introduced Session
2026 Regular Session
Bill Summary
Making a violation of certain provisions of law regarding the manufacture, sale, delivery, holding, or offering for sale certain cosmetic products an unfair, abusive, or deceptive trade practice; providing that a person who violates the is liable for certain civil damages resulting from actual harm sustained by an individual; requiring the Department of Health and the Attorney General to develop a plan for a special fund to support research and treatment related to conditions caused by harmful chemicals in cosmetic products; etc.
AI Summary
This bill, known as the Crown and Care Act, aims to protect communities from harmful hair chemicals by making it an unfair, abusive, or deceptive trade practice to knowingly manufacture, sell, deliver, hold, or offer for sale cosmetic products containing certain intentionally added ingredients, including specific phthalates, formaldehyde, mercury, parabens, certain hair dye chemicals, and per- and polyfluoroalkyl substances (PFAS). A cosmetic is defined as any substance applied to the human body for cleansing, beautifying, promoting attractiveness, or altering appearance, excluding soap. Violators of these provisions are liable for civil damages resulting from actual harm sustained by an individual, with a three-year statute of limitations for bringing such actions after the harm is discovered or should have been discovered. The bill also allows courts to award treble damages, punitive damages for willful violations, and reasonable attorney's fees to prevailing plaintiffs. Furthermore, the Department of Health is empowered to investigate complaints and inspect premises to ensure compliance. Importantly, the bill mandates the Department of Health and the Attorney General to develop a plan for a special fund, to be established by December 1, 2026, which will support research and treatment for conditions like fibroids, uterine cancer, and hair loss potentially caused by these harmful chemicals, with funds primarily sourced from penalties collected under the Consumer Protection Act.
Committee Categories
Budget and Finance, Health and Social Services
Sponsors (1)
Last Action
Approved by the Governor - Chapter 283 (on 04/28/2026)
Bill Topics
Banking, Finance, and Domestic Commerce
- ‐ Consumer Safety and Consumer Fraud
Health
- ‐ Research and Development
- ‐ Treatment of Specific Diseases
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/SB0656?ys=2026RS | 02/06/2026 |
| BillText | https://mgaleg.maryland.gov/2026RS/Chapters_noln/CH_283_sb0656e.pdf | 05/05/2026 |
| BillText | https://mgaleg.maryland.gov/2026RS/bills/sb/sb0656e.pdf | 04/10/2026 |
| Favorable with Amendments 693329/1 Adopted | https://mgaleg.maryland.gov/2026RS/amds/bil_0006/sb0656_69332901.pdf | 04/03/2026 |
| Vote Image | https://mgaleg.maryland.gov/2026RS/votes_comm/sb0656_hlt.pdf | 04/02/2026 |
| BillText | https://mgaleg.maryland.gov/2026RS/bills/sb/sb0656t.pdf | 03/17/2026 |
| Favorable with Amendments 143820/1 Adopted | https://mgaleg.maryland.gov/2026RS/amds/bil_0006/sb0656_14382001.pdf | 03/17/2026 |
| Vote Image | https://mgaleg.maryland.gov/2026RS/votes_comm/sb0656_fin.pdf | 03/13/2026 |
| BillText | https://mgaleg.maryland.gov/2026RS/bills/sb/sb0656f.pdf | 02/06/2026 |
Loading...